Previously, LIMD2 has been found to be overexpressed in many cancer types, including PTC, bladder, melanoma, breast, and non-small cell lung cancer, while its expression is negligible in normal tissues [6,7,8]. This evidence concerns the gene LIMD2 and melanoma.